7o4d: Difference between revisions

From Proteopedia
Jump to navigationJump to search
OCA (talk | contribs)
New page: '''Unreleased structure''' The entry 7o4d is ON HOLD until Paper Publication Authors: Gould, N.L., Scherer, G.R., Carvalh, S., Shurrush, K., Edry, E., Elkobi, A., David, O., Dym, O., Al...
 
OCA (talk | contribs)
No edit summary
 
(2 intermediate revisions by the same user not shown)
Line 1: Line 1:
'''Unreleased structure'''


The entry 7o4d is ON HOLD  until Paper Publication
==QR2 inhibitor from a novel sulfanamide series to tackle age related oxidative stress and cognitive decline==
 
<StructureSection load='7o4d' size='340' side='right'caption='[[7o4d]], [[Resolution|resolution]] 2.25&Aring;' scene=''>
Authors: Gould, N.L., Scherer, G.R., Carvalh, S., Shurrush, K., Edry, E., Elkobi, A., David, O., Dym, O., Albeck, S., Peleg, Y., Germain, N., Babaev, I., Sharir, H., Lefker, B., Subramanyam, C., Barr, H., Rosenblum, K.
== Structural highlights ==
 
<table><tr><td colspan='2'>[[7o4d]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=7O4D OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=7O4D FirstGlance]. <br>
Description: QR2 inhibitor from a novel sulfanamide series to tackle age related oxidative stress and cognitive decline
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.249&#8491;</td></tr>
[[Category: Unreleased Structures]]
<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=FAD:FLAVIN-ADENINE+DINUCLEOTIDE'>FAD</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene>, <scene name='pdbligand=V1Z:8-methyl-2-(4-methyl-3-piperazin-1-ylsulfonyl-phenyl)imidazo[1,2-a]pyridine'>V1Z</scene>, <scene name='pdbligand=ZN:ZINC+ION'>ZN</scene></td></tr>
[[Category: Germain, N]]
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=7o4d FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=7o4d OCA], [https://pdbe.org/7o4d PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=7o4d RCSB], [https://www.ebi.ac.uk/pdbsum/7o4d PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=7o4d ProSAT]</span></td></tr>
[[Category: Subramanyam, C]]
</table>
[[Category: Carvalh, S]]
== Function ==
[[Category: Shurrush, K]]
[https://www.uniprot.org/uniprot/NQO2_HUMAN NQO2_HUMAN] The enzyme apparently serves as a quinone reductase in connection with conjugation reactions of hydroquinones involved in detoxification pathways as well as in biosynthetic processes such as the vitamin K-dependent gamma-carboxylation of glutamate residues in prothrombin synthesis.<ref>PMID:18254726</ref>
[[Category: Albeck, S]]
== References ==
[[Category: Rosenblum, K]]
<references/>
[[Category: Lefker, B]]
__TOC__
[[Category: Babaev, I]]
</StructureSection>
[[Category: Peleg, Y]]
[[Category: Homo sapiens]]
[[Category: David, O]]
[[Category: Large Structures]]
[[Category: Elkobi, A]]
[[Category: Albeck S]]
[[Category: Sharir, H]]
[[Category: Babaev I]]
[[Category: Edry, E]]
[[Category: Barr H]]
[[Category: Barr, H]]
[[Category: Carvalh S]]
[[Category: Scherer, G.R]]
[[Category: David O]]
[[Category: Dym, O]]
[[Category: Dym O]]
[[Category: Gould, N.L]]
[[Category: Edry E]]
[[Category: Elkobi A]]
[[Category: Germain N]]
[[Category: Gould NL]]
[[Category: Lefker B]]
[[Category: Peleg Y]]
[[Category: Rosenblum K]]
[[Category: Scherer GR]]
[[Category: Sharir H]]
[[Category: Shurrush K]]
[[Category: Subramanyam C]]

Latest revision as of 12:44, 1 February 2024

QR2 inhibitor from a novel sulfanamide series to tackle age related oxidative stress and cognitive decline

7o4d, resolution 2.25Å

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)

OCA